These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 1902993
1. The role of plasminogen activator in adhesion prevention. Menzies D, Ellis H. Surg Gynecol Obstet; 1991 May; 172(5):362-6. PubMed ID: 1902993 [Abstract] [Full Text] [Related]
2. Effect of varying days of tissue plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model. Dunn RC, Mohler M. J Surg Res; 1993 Mar; 54(3):242-5. PubMed ID: 8474240 [Abstract] [Full Text] [Related]
4. Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model. Yeo Y, Bellas E, Highley CB, Langer R, Kohane DS. Biomaterials; 2007 Sep; 28(25):3704-13. PubMed ID: 17512979 [Abstract] [Full Text] [Related]
6. Pharmacologic inhibition of adhesion formation and peritoneal tissue-type plasminogen activator activity. Reed KL, Stucchi AF, Becker JM. Semin Reprod Med; 2008 Jul; 26(4):331-40. PubMed ID: 18756410 [Abstract] [Full Text] [Related]
7. The effects of intraperitoneal sildenafil administration on healing of left colonic anastomoses and intra-abdominal adhesion formation in the presence of intra-abdominal infection. Ayten R, Cetinkaya Z, Girgin M, Ozercan I, Ustundag B, Aygen E. Dis Colon Rectum; 2008 Dec; 51(12):1837-41. PubMed ID: 18607551 [Abstract] [Full Text] [Related]
8. Effect of honey versus intergel in intraperitoneal adhesion prevention and colonic anastomotic healing: a randomized controlled study in rats. Saber A. Int J Surg; 2010 Dec; 8(2):121-7. PubMed ID: 19961959 [Abstract] [Full Text] [Related]
9. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator. Orita H, Fukasawa M, Girgis W, diZerega GS. Int J Fertil; 1991 Dec; 36(3):172-7. PubMed ID: 1678373 [Abstract] [Full Text] [Related]
10. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog. Collen D, Stassen JM, Yasuda T, Refino C, Paoni N, Keyt B, Roskams T, Guerrero JL, Lijnen HR, Gold HK. Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384 [Abstract] [Full Text] [Related]
11. Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits. Vaughan DE, Declerck PJ, De Mol M, Collen D. J Clin Invest; 1989 Aug; 84(2):586-91. PubMed ID: 2503540 [Abstract] [Full Text] [Related]
12. Regulation of expression of tissue plasminogen activator and plasminogen activator inhibitor-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Diamond MP, El-Hammady E, Wang R, Kruger M, Saed G. Am J Obstet Gynecol; 2004 Apr; 190(4):926-34. PubMed ID: 15118614 [Abstract] [Full Text] [Related]
14. Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats. Atta HM, Al-Hendy A, El-Rehany MA, Dewerchin M, Abdel Raheim SR, Abdel Ghany H, Fouad R. Surgery; 2009 Jul; 146(1):12-7. PubMed ID: 19541005 [Abstract] [Full Text] [Related]
15. Adhesion formation and prevention after peritoneal injury and repair in the rabbit. McDonald MN, Elkins TE, Wortham GF, Stovall TG, Ling FW, McNeeley SG. J Reprod Med; 1988 May; 33(5):436-9. PubMed ID: 3290475 [Abstract] [Full Text] [Related]
16. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation. Lai HS, Chen Y, Chang KJ, Chen WJ. J Gastroenterol; 2003 May; 38(6):555-60. PubMed ID: 12825131 [Abstract] [Full Text] [Related]
17. Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study. Hellebrekers BW, Trimbos-Kemper TC, Boesten L, Jansen FW, Kolkman W, Trimbos JB, Press RR, van Poelgeest MI, Emeis SJ, Kooistra T. Fertil Steril; 2009 Apr; 91(4):1204-14. PubMed ID: 18353314 [Abstract] [Full Text] [Related]
18. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator. Menzies D, Ellis H. J R Soc Med; 1989 Sep; 82(9):534-5. PubMed ID: 2507782 [Abstract] [Full Text] [Related]
19. The effect of urokinase in the prevention of intraperitoneal adhesions; role of blood in their formation. Birkenfeld A, Schenker JG. Ann Chir Gynaecol; 1983 Sep; 72(5):246-9. PubMed ID: 6660826 [Abstract] [Full Text] [Related]
20. Prevention of adhesions by sodium chromoglycate, dexamethasone, saline and aprotinin after pelvic surgery. Kucukozkan T, Ersoy B, Uygur D, Gundogdu C. ANZ J Surg; 2004 Dec; 74(12):1111-5. PubMed ID: 15574156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]